We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 492

NIH to fund research centers targeting genetic causes of CHD

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

The National Institutes of Health (NIH) will award more than $2 million in fiscal year 2015 to research centers that will join the Pediatric Cardiac

County pharmaceutical disposal law at issue before Ninth Circuit

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

The Ninth Circuit Court of Appeals has heard oral argument in an appeal challenging an Alameda County, California law that requires pharmaceutical

Massachusetts Governor signs law increasing compounding pharmacy oversight

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

Massachusetts Gov. Patrick Duval (D) has signed into law a bill (H. 4235) that will impose on compounding pharmacies new licensing, labeling

Court orders dispute over 23andMe DNA test kits to arbitration

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

A multidistrict litigation court in California has ordered false-advertising, class-action claims filed against personal genetics company 23andMe to

Challenge to AIA first-to-file rule fails for lack of standing

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

Ruling that it had jurisdiction to consider a constitutional challenge to the America Invents Act (AIA), the Federal Circuit Court of Appeals has

Oregon settles generic safety suit with Ranbaxy for $2.3 million

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

India-based Ranbaxy Laboratories has reportedly agreed to settle claims that that the manufacturing process for its prescription drugs sold in Oregon

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

The U.S. Food and Drug Administration issues guidance titled "Pharmacy Compounding of Human Drug Products Under Section 503A of the Federal, Food

AIA did not constitute a pardon for past false-marking acts

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

The Federal Circuit Court of Appeals has dismissed claims that the America Invents Act (AIA), which made significant changes to the false-marking

Patent damage awards studied

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

Legal analytics firm Lex Machina has issued a "Patent Litigation Damages Report" that analyzes patent litigation damages awarded in U.S. district

Executive advisory group recommends antibiotics R&D incentives

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • July 17 2014

The U.S. President's Council of Advisors on Science and Technology (PCAST) has reportedly approved a report that endorses a plan to help drug makers